March 12, 2015 / 3:37 PM / 3 years ago

GSK launches $890mln placement in Aspen Pharmacare - source

LONDON, March 12 (Reuters) - GlaxoSmithKline has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday.

GSK said earlier on Thursday that it had launched the sale of around half its holding in the company. A price range of 365-385 rand per share has been set for the placement, representing a discount of 5.3-10.2 percent to the closing price.

The share sale is being run by Citi and UBS. (Reporting By Freya Berry and Vikram Subhedar; editing by Pamela Barbaglia)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below